LOWER LEVELS OF URINARY 2-AMINO-3,8-DIMETHYLIMIDAZO[4,5-F]QUINOXALINE (MEIQX) IN HUMANS WITH HIGHER CYP1A2 ACTIVITY

被引:30
|
作者
SINHA, R
ROTHMAN, N
MARK, SD
MURRAY, S
BROWN, ED
LEVANDER, OA
DAVIES, DS
LANG, NP
KADLUBAR, FF
HOOVER, RN
机构
[1] ROYAL POSTGRAD MED SCH,DEPT CLIN PHARMACOL,LONDON W12 0NN,ENGLAND
[2] USDA ARS,BELTSVILLE HUMAN NUTR RES CTR,NUTR REQUIREMENTS & FUNCT LAB,BELTSVILLE,MD 20705
[3] UNIV ARKANSAS MED SCI HOSP,ARKANSAS CANC RES CTR,LITTLE ROCK,AR 72205
[4] NATL CTR TOXICOL RES,JEFFERSON,AR 72079
关键词
D O I
10.1093/carcin/16.11.2859
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heterocyclic aromatic amines (HAAs), such as 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx), are metabolically activated by cytochrome P4501A2 (CYP1A2) and N-acetyltransferase (NAT2), We examined the relationship between CYP1A2 and NAT2 activity and the excretion of total unconjugated MeIQx in 66 healthy subjects, The subjects ate a controlled diet for 7 days containing lean ground beef cooked at low temperature. On day 8, they were tested for CYP1A2, and NAT2 activity by caffeine phenotyping, On the evening of day 8, subjects consumed lean ground beef cooked at high temperature containing 9.0 ng of MeIQx/g of meat. The subjects ate 3.1-4.0 g meat/kg body wt. Twelve-hour urine samples were collected and MeIQx was measured by gas chromatography-mass spectrometry, Using linear regression analyses, we found that higher CYP1A2 activity was associated with lower levels of total unconjugated MeIQx in the urine (P = 0.008) when adjusted for amount of meat eaten, while NAT2 activity showed no relationship with the latter, This suggests that a greater percentage of MeIQx is converted to metabolites such as the N-hydroxy derivative when CYP1A2 activity is higher, This finding supports the concept that interindividual variation in CYP1A2 activity may be relevant for cancers associated with exposure to HAAs.
引用
收藏
页码:2859 / 2861
页数:3
相关论文
共 50 条
  • [21] Existence of no hepatocarcinogenic effect levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without coadministration with ethanol
    Wanibuchi, Hideki
    Wei, Min
    Karim, M. Rezaul
    Morimura, Keiichirou
    Doi, Kenichiro
    Kinoshita, Anna
    Fukushima, Shoji
    TOXICOLOGIC PATHOLOGY, 2006, 34 (03) : 232 - 236
  • [22] FORMATION OF MUTAGENS, 2-AMINO-3,8-DIMETHYLIMIDAZO[4,5-F]QUINOXALINE (MEIQX) AND 2-AMINO-3,4,8-TRIMETHYLIMIDAZO[4,5-F]QUINOXALINE (4,8-DIMEIQX), IN HEATED FISH MEATS
    KIKUGAWA, K
    KATO, T
    MUTATION RESEARCH, 1987, 179 (01): : 5 - 14
  • [23] Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity
    Park, CB
    Kim, DJ
    Uehara, N
    Takasuka, N
    Hiroyasu, BT
    Tsuda, H
    CANCER LETTERS, 1999, 139 (02) : 177 - 182
  • [24] THE PRESENCE OF 2-AMINO-3,8-DIMETHYLIMIDAZO[4,5-F]QUINOXALINE IN SMOKED DRY BONITO (KATSUOBUSHI)
    KIKUGAWA, K
    KATO, T
    HAYATSU, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1986, 77 (02): : 99 - 102
  • [25] Mutational and DNA binding specificity of the carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
    Solomon, MS
    Morgenthaler, PML
    Turesky, RJ
    Essigmann, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) : 18368 - 18374
  • [26] Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
    Fukushima, S
    Wanibuchi, H
    Morimura, K
    Wei, M
    Nakae, D
    Konishi, Y
    Tsuda, H
    Takasuka, N
    Imaida, K
    Shirai, T
    Tatematsu, M
    Tsukamoto, T
    Hirose, M
    Furukawa, F
    CANCER LETTERS, 2003, 191 (01) : 35 - 40
  • [27] Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats
    Fujita, K
    Ohnishi, T
    Sekine, K
    Iigo, M
    Tsuda, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (06): : 616 - 625
  • [28] Disposition of the Dietary Mutagen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline in Healthy and Pancreatic Cancer Compromised Humans
    Malfatti, Michael A.
    Kuhn, Edward A.
    Turteltaub, Kenneth W.
    Vickers, Selwyn M.
    Jensen, Eric H.
    Strayer, Lori
    Anderson, Kristin E.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2016, 29 (03) : 352 - 358
  • [29] HUMAN URINARY-EXCRETION OF SULFAMATE AND GLUCURONIDE CONJUGATES OF 2-AMINO-3,8-DIMETHYLIMIDAZO[4,5-F]QUINOXALINE (MELQX)
    STILLWELL, WG
    TURESKY, RJ
    GROSS, GA
    SKIPPER, PL
    TANNENBAUM, SR
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1994, 3 (05) : 399 - 405
  • [30] MAJOR ROUTES OF METABOLISM OF THE FOODBORNE CARCINOGEN 2-AMINO-3,8-DIMETHYLIMIDAZO[4,5-F]QUINOXALINE IN THE RAT
    TURESKY, RJ
    AESCHBACHER, HU
    WURZNER, HP
    SKIPPER, PL
    TANNENBAUM, SR
    CARCINOGENESIS, 1988, 9 (06) : 1043 - 1048